Overview of SGLT

Monthly Searches
1,600
Competition
LOW
Interest Over Past 5 Years
90.00%
Interest Over Past 12 Months
18.75%
Monthly searches for last 5 years
Monthly searches for last 12 months
What is "SGLT"?
SGLT, or sodium-glucose transport proteins, are a family of glucose transporters found in the intestinal mucosa and renal proximal convoluted tubules. SGLT2 inhibitors are a class of medication used to treat type 2 diabetes by blocking the reabsorption of glucose in the kidneys and promoting its excretion in the urine. Common examples of SGLT2 inhibitors include Invokana, Farxiga, Jardiance, and Steglatro. SGLT1 is responsible for glucose absorption in the small intestine and reabsorbing about 3% of the filtered glucose load in the renal proximal tubule segment 3. SGLT2, on the other hand, is responsible for the majority of glucose reuptake in the tubular system of the kidney. SGLT2 inhibitors are versatile medications with glycemic and nonglycemic benefits that help lower blood sugar levels in adults with type 2 diabetes.
Category tags for SGLT
TherapyHeartDrugOsmosisKidneyHealth technologyPharmaceutical drugUrinary tract infectionDrug classMechanism of actionMetabolismGlucagon-like peptide-1ResearchMedicationType 2 DiabetesBlood Sugar LevelsHealthcareDiabetes treatmentPharmaceuticalDrug therapyKidney diseaseGlycemic Control
RamenApps Analysis

Based on the search trends and associated terms, it is clear that there is a growing interest in SGLT2 inhibitors among people interested in therapy, heart health, and kidney health. The current monthly search volume for "sglt" is low, but related terms like "sglt2 inhibitors" have a higher search volume. In terms of competition, SGLT has a low competition index of 54. Popular YouTube videos related to SGLT also suggest a growing interest in this topic. Overall, with the rising interest in SGLT2 inhibitors and related health categories, there appears to be potential for growth and innovation in this field. The projected future of SGLT looks promising, as evidenced by increasing interest and related searches. However, more research and studies are needed to fully understand the long-term effects and potential of SGLT2 inhibitors.